Abbott Diabetes Care Issues Warning on Inaccurate Glucose Readings: What You Need to Know
Abbott Diabetes Care has issued a warning regarding inaccurate glucose readings on some of its devices, which may have led to seven deaths and numerous serious injuries. The company identified the issue during internal testing, affecting around 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors from a specific production line. Approximately 1.5 million of these devices have expired or been used, according to Abbott.
The company advised customers to discontinue using the affected sensors and dispose of them if confirmed to be faulty. Incorrect low glucose readings could result in improper treatment decisions for individuals with diabetes, potentially leading to health risks or complications. Abbott assured that it is actively producing sensors and does not anticipate significant supply disruptions due to this issue.
Out of the reported deaths and severe injuries, all fatalities occurred outside the U.S., while 57 severe injuries were documented in the U.S. Diabetes is a condition that impacts insulin production and response in the body, making glucose monitoring crucial for managing blood sugar levels, dietary choices, and medication decisions.
Customers with potentially affected sensors are encouraged to check their device status on FreeStyleCheck.com. Abbott will replace defective sensors free of charge for affected individuals. For more details on the recall, the Food and Drug Administration offers additional information.
In conclusion, Abbott Diabetes Care has taken proactive measures to address the issue of inaccurate glucose readings on certain sensors, prioritizing customer safety and well-being. It is essential for individuals with diabetes to verify the status of their devices and take necessary steps to ensure accurate monitoring and treatment.